Page last updated: 2024-10-17

phosphonoacetic acid and Neoplasm Metastasis, Unknown Primary

phosphonoacetic acid has been researched along with Neoplasm Metastasis, Unknown Primary in 1 studies

Phosphonoacetic Acid: A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
phosphonoacetic acid : A member of the class of phosphonic acids that is phosphonic acid in which the hydrogen attached to the phosphorous is replaced by a carboxymethyl group.

Research Excerpts

ExcerptRelevanceReference
"5-Fluorouracil (5-FU) has modest activity as a single agent in a number of human adenocarcinomas."9.07A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site. ( Coit, D; Colofiore, J; Kelsen, D; Martin, DS; Sawyer, R, 1992)
"5-Fluorouracil (5-FU) has modest activity as a single agent in a number of human adenocarcinomas."5.07A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site. ( Coit, D; Colofiore, J; Kelsen, D; Martin, DS; Sawyer, R, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelsen, D1
Martin, DS1
Colofiore, J1
Sawyer, R1
Coit, D1

Trials

1 trial available for phosphonoacetic acid and Neoplasm Metastasis, Unknown Primary

ArticleYear
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site.
    Cancer, 1992, Oct-01, Volume: 70, Issue:7

    Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protoco

1992